Anna Selmecki, PhD

Assistant Professor and Dean's Fellow
Kavli Fellow, National Academy of Sciences, Department of Microbiology and Immunology

Anna Selmecki

Contact Info

selmecki@umn.edu

Office Phone (612) 625-2263

Office Address:
3-105 MRF
689 23rd Ave SE
Minneapolis, MN 55455

Mailing Address:
Department of Microbiology and Immunology
3-105 Microbiology Research Facility (MRF)
CDC: 2821A
689 23rd Ave SE
Minneapolis, MN 55455-1507

Lab Address:
3-153 MRF
689 23rd Ave SE
Minneapolis, MN 55455

Assistant Professor and Dean's Fellow
Kavli Fellow, National Academy of Sciences
, Department of Microbiology and Immunology

Faculty, Microbiology, Immunology and Cancer Biology (MICaB) Ph.D. Graduate Program


Postdoctoral Fellow, Dana-Farber Cancer Institute and Harvard Medical School

Ph.D., University of Minnesota, Molecular Cellular Developmental Biology and Genetics

B.A., College of St. Benedict/St. John's University, Chemistry

Summary

Expertise

Aneuploidy and Genome Stability, Fungal Pathogenesis, Antifungal Drug resistance

Research

Research Summary/Interests

Understanding the dynamics of how growth-promoting mutations arise and accumulate in a population of cells is a fundamental problem underlying our understanding of drug resistance, tumorigenesis, and the treatment of cancer. We use experimental evolution, mathematical modeling, and comparative genomics to understand the impact of mutations on the adaptation of a cell and its surrounding population.

We employ diverse yeast model systems (Saccharomyces cerevisiae, Candida albicans, Candida auris, etc.) to understand how genome instability contributes to adaptation (eg. antifungal drug resistance) and determine the underlying mechanisms that promote genome instability.

In the human fungal pathogen Candida albicans, genome rearrangements resulting in copy number variation (CNV) and loss of heterozygosity (LOH) confer increased virulence and antifungal drug resistance, yet the mechanisms driving these rearrangements are not completely understood. We recently identified an extensive array of long repeat sequences (65–6499 bp) that are associated with CNV, LOH, and chromosomal inversions and are a significant source of genome plasticity across diverse strain backgrounds - including clinical, environmental, and experimentally evolved C. albicans isolates. Many of these long repeat sequences were uncharacterized and encompass one or more coding sequences that are actively transcribed. Further, the repeats associated with genome rearrangements were predominantly inverted and separated by up to ~1.6 Mb, an extraordinary distance for homology-based DNA repair/recombination in yeast!

We also utilize flow cytometry-based systems that enable us to detect the acquisition and spread of beneficial mutations within populations. We found that polyploid S. cerevisiae adapted more rapidly than isogenic haploid or diploid cells in poor carbon medium, and that polyploid cells acquired more mutations, including point mutations, large segmental aneuploidies, and whole chromosome aneuploidies (Selmecki et al., Nature 2015). Additionally, polyploid cells acquired a broader spectrum of beneficial mutations than lower ploidy cells (Scott et al., MBE 2017). We continue to use these ploidy lineages to study how changes in chromosome number (ploidy and aneuploidy), cell size, and environment affect genome stability and evolvability.

Our previous research identified chromosome aneuploidy as a driver for the acquisition of antifungal drug resistance in the pathogenic yeast C. albicans (Selmecki et al., Science 2006). We found that aneuploid cells arose within a population very rapidly in the presence of antifungal drug (Selmecki et al., PLoS Genetics 2009), and that increased copy number of two specific genes found on the most common aneuploid chromosome provided the drug resistance phenotype (Selmecki et al., Molecular Microbiology 2008).